Deleted Journal,
Год журнала:
2022,
Номер
49(4), С. 282 - 293
Опубликована: Янв. 1, 2022
Infectious
diseases
have
evolutionally
challenged
human
with
annual
mortality
over
10
million
individuals
worldwide.They
eluded
all
developed
prevention
and
control
strategies.New
pathogens
(e.g.,
H7N9
influenza
virus
in
2013,
H5N1,
H1N1,
Zika
2016
Chikungunya
2019
were
continuously
added
into
the
endemic/epidemic
list
1
.Recently,
we
been
threatened
a
pandemic
of
SARS-CoV-2,
new
strain
Coronavirus
that
was
sequenced
early
2020
Wuhan,
Hubei,
China.The
first
case
identified
December
2019.Since
then,
number
patients
deaths
due
to
disease,
termed
Disease
(COVID-19)
increasing
spreading
across
globe
rapidly
2
.In
January
2020,
World
Health
Organization
(WHO)
had
declared
SARS-CoV-2
epidemic
global
health
emergency.In
March
WHO
officially
outbreak
pandemic.The
COVID-19
has
an
emergent
crisis
requires
urgent
solutions.The
total
confirmed
cases
approached
600
more
than
six
globally
by
end
May
2022.The
created
various
issues
on
healthcare
systems
worldwide,
overwhelming
hospital
intensive
care
unit
(ICUs)
lacking
mechanical
ventilation
handle
acute
lung
injury
(ALI)
respiratory
distress
syndrome
(ARDS)
[3][4]
.Clinical
manifestations
partly
understood.The
clinical
outcomes
ranged
from
asymptomatic,
mild,
moderate,
severe,
critically
severe.Common
symptoms
included
cough,
fever,
dyspnea,
muscle
pain,
sputum
production
sore
throat.Even
though
most
exhibited
mild
symptoms,
some
suffered
organ
damage,
e.g.,
kidney,
cardiac
liver
dysfunction
[5][6]
.Patients
cardiovascular
diseases,
hypertension
tract
frequently
associated
ICU
admission
poor
5
.The
rate
per
diagnosed
roughly
3.4%
depending
age
conditions
7
listed
omicron
(B.1.1.529)as
variant
concern
(VOC)
since
November
2021.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2022,
Номер
12
Опубликована: Окт. 21, 2022
As
new
pathogens
emerge,
challenges
must
be
faced.
This
is
no
different
in
infectious
disease
research,
where
identifying
the
best
tools
available
laboratories
to
conduct
an
investigation
can,
at
least
initially,
particularly
complicated.
However,
context
of
emerging
virus,
such
as
SARS-CoV-2,
which
was
recently
detected
China
and
has
become
a
global
threat
healthcare
systems,
developing
models
infection
pathogenesis
urgently
required.
Cell-based
approaches
are
crucial
understanding
coronavirus
biology,
growth
kinetics,
tropism.
Usually,
laboratory
cell
lines
first
line
experimental
study
viral
pathogenicity
perform
assays
aimed
screening
antiviral
compounds
efficient
blocking
replication
viruses,
saving
time
resources,
reducing
use
animals.
determining
ideal
type
can
challenging,
especially
when
several
researchers
have
adapt
their
studies
specific
requirements.
review
strives
guide
scientists
who
venturing
into
studying
SARS-CoV-2
help
them
choose
right
cellular
models.
It
revisits
basic
concepts
virology
presents
currently
Stem Cell Research & Therapy,
Год журнала:
2023,
Номер
14(1)
Опубликована: Окт. 10, 2023
Abstract
Understanding
mechanisms
and
manifestations
of
cardiovascular
risk
factors,
including
diabetes,
on
vascular
cells
such
as
endothelial
cells,
pericytes,
smooth
muscle
remains
elusive
partly
due
to
the
lack
appropriate
disease
models.
Therefore,
here
we
explore
different
aspects
for
development
advanced
3D
in
vitro
models
that
recapitulate
human
blood
vessel
complications
using
patient-derived
induced
pluripotent
stem
which
retain
epigenetic,
transcriptomic,
metabolic
memory
their
patient-of-origin.
In
this
review,
highlight
superiority
organoids
over
conventional
2D
cell
culture
systems
research.
We
outline
key
benefits
both
health
contexts
discuss
current
challenges
associated
with
organoid
technology,
providing
potential
solutions.
Furthermore,
diverse
applications
emphasize
importance
incorporating
all
relevant
cellular
components
a
model
accurately
pathophysiology.
As
specific
example,
present
comprehensive
overview
diabetic
vasculopathy,
demonstrating
how
interplay
types
is
critical
successful
modelling
complex
processes
vitro.
Finally,
propose
strategy
creating
an
organ-specific
vasculopathy
model,
serving
valuable
template
other
diseases
by
disease-specific
stressors
organotypic
modifications.
Graphical
abstract
Journal of Clinical Medicine,
Год журнала:
2022,
Номер
11(15), С. 4464 - 4464
Опубликована: Июль 31, 2022
Addressing
factors
modulating
COVID-19
is
crucial
since
abundant
clinical
evidence
shows
that
outcomes
are
markedly
heterogeneous
between
patients.
This
requires
identifying
the
and
understanding
how
they
mechanistically
influence
COVID-19.
Here,
we
describe
eleven
selected
(age,
sex,
genetic
factors,
lipid
disorders,
heart
failure,
gut
dysbiosis,
diet,
vitamin
D
deficiency,
air
pollution
exposure
to
chemicals)
by
applying
Adverse
Outcome
Pathway
(AOP),
which
well-established
in
regulatory
toxicology.
framework
aims
model
sequence
of
events
leading
an
adverse
health
outcome.
Several
linear
AOPs
depicting
pathways
from
binding
virus
ACE2
up
observed
have
been
developed
integrated
into
a
network
offering
unique
overview
mechanisms
underlying
disease.
As
SARS-CoV-2
infectibility
activity
major
starting
points
inflammatory
response
central
development
COVID-19,
evaluated
those
intrinsic
extrinsic
modulate
processes
impacting
outcomes.
Applying
this
AOP-aligned
approach
enables
identification
current
knowledge
gaps
orientating
for
further
research
allows
propose
biomarkers
identify
high-risk
also
facilitates
expertise
synergy
different
disciplines
address
public
issues.
Diagnostics,
Год журнала:
2025,
Номер
15(2), С. 229 - 229
Опубликована: Янв. 20, 2025
COVID-19
has
caused
widespread
morbidity
and
mortality,
with
its
effects
extending
to
multiple
organ
systems.
Despite
known
risk
factors
for
severe
disease,
including
advanced
age
underlying
comorbidities,
patient
outcomes
can
vary
significantly.
This
variability
complicates
efforts
predict
disease
progression
tailor
treatment
strategies.
While
diagnostic
therapeutic
approaches
are
still
under
debate,
RNA
sequencing
(RNAseq)
emerged
as
a
promising
tool
provide
deeper
insights
into
the
pathophysiology
of
guide
personalized
treatment.
A
comprehensive
literature
review
was
conducted
using
PubMed,
Scopus,
Web
Science,
Google
Scholar.
We
employed
Medical
Subject
Headings
(MeSH)
terms
relevant
keywords
identify
studies
that
explored
role
RNAseq
in
diagnostics,
prognostics,
therapeutics.
proven
instrumental
identifying
molecular
biomarkers
associated
severity
patients
COVID-19.
It
allows
differentiation
between
asymptomatic
symptomatic
individuals
sheds
light
on
immune
response
mechanisms
contribute
progression.
In
critically
ill
patients,
been
crucial
key
genes
may
outcomes,
guiding
decisions,
assessing
long-term
virus.
Additionally,
helped
understanding
persistence
viral
after
recovery,
offering
new
management
post-acute
sequelae,
long
COVID.
significantly
improves
management,
particularly
by
enhancing
accuracy,
personalizing
treatment,
predicting
responses.
refines
stratification,
improving
holds
promise
targeted
interventions
both
acute
Viruses,
Год журнала:
2025,
Номер
17(3), С. 349 - 349
Опубликована: Фев. 28, 2025
Studies
on
human
respiratory
viral
infections
and
pathogenesis
have
historically
been
conducted
using
immortalized
cells
animal
models.
However,
these
models
are
limited
in
their
ability
to
recapitulate
the
complex
structure
of
airway
or
full
spectrum
disease
symptoms
observed
humans.
Recently,
nose
lung
organoids
revolutionized
culture
complexity
infection
biology
demonstrated
potential
for
research
virus
In
this
opinion,
we
review
how
advances
organoid
models,
which
able
express
all
cell
types
epithelia,
i.e.,
Club,
basal,
goblet,
ciliated
cells,
provided
novel
insight
into
pathogenesis,
age-dependent
susceptibility,
attenuation
signature,
immune
mechanisms
viruses
such
as
SARS-CoV-2,
syncytial
virus,
influenza
virus.
The
also
studying
hitherto
uncultivable
be
useful
studies
zoonotic
risk.
Organoids,
Год журнала:
2023,
Номер
2(2), С. 82 - 101
Опубликована: Май 11, 2023
Bovine
respiratory
disease
(BRD)
is
the
leading
cause
of
morbidity
and
mortality
in
feedlot
cattle.
herpesvirus-1
(BHV-1)
one
main
culprits
BRD;
however,
research
on
BHV-1
hampered
by
lack
suitable
models
for
infection
drug
testing.
In
this
study,
we
established
a
novel
bovine
tracheal
organoid
culture
grown
basement
membrane
extract
type
2
(BME2)
matrix
compared
it
with
air–liquid
interface
(ALI)
system.
After
differentiation,
matrix-embedded
organoids
developed
beating
cilia
demonstrated
transcriptomic
profile
similar
to
ALI
The
were
also
highly
susceptible
immune
stimulation
Pam2Cys,
an
immunomodulator,
which
resulted
robust
cytokine
production
antimicrobial
peptide
mRNA
upregulation.
However,
treatment
cultures
Pam2Cys
was
not
sufficient
inhibit
viral
or
replication,
suggesting
role
non-epithelial
cellular
microenvironment
vivo.
iScience,
Год журнала:
2023,
Номер
26(8), С. 107374 - 107374
Опубликована: Июль 13, 2023
The
COVID-19
pandemic
continues
to
be
a
health
crisis
with
major
unmet
medical
needs.
early
responses
from
airway
epithelial
cells,
the
first
target
of
virus
regulating
progression
toward
severe
disease,
are
not
fully
understood.
Primary
human
air-liquid
interface
cultures
representing
broncho-alveolar
epithelia
were
used
study
kinetics
and
dynamics
SARS-CoV-2
variants
infection.
infection
measured
by
nucleoprotein
expression,
was
late
event
appearing
between
day
4–6
post
for
Wuhan-like
virus.
Other
demonstrated
increasingly
accelerated
timelines
All
triggered
similar
transcriptional
signatures,
an
"early"
inflammatory/immune
signature
preceding
"late"
type
I/III
IFN,
but
differences
in
quality
found,
consistent
timing
expression.
Response
spatially
organized:
CSF3
expression
basal
cells
CCL20
apical
cells.
Thus,
triggers
specific
modulated
over
time
engage
different
arms
immune
response.
Addressing
factors
modulating
COVID-19
is
crucial
since
abundant
clinical
evidence
shows
that
outcomes
are
markedly
heterogeneous
between
patients.
This
requires
identifying
the
and
understanding
how
they
mechanistically
influence
COVID-19.
Here,
we
describe
eleven
selected
by
applying
Adverse
Outcome
Pathway
(AOP)
framework
well-established
in
regulatory
toxicology.
aims
to
model
sequence
of
events
starting
from
an
initial
interaction
a
stressor
with
organism
progress
through
key
biological
leading
adverse
health
outcome.
Several
linear
AOPs
depicting
pathways
binding
virus
ACE2
up
observed
patients
have
been
developed
integrated
into
network
offering
unique
overview
mechanisms
underlying
disease.
As
SARS-CoV-2
infectibility
activity
major
points
inflammatory
response
central
development
COVID-19,
evaluated
intrinsic
extrinsic
modulate
those
processes
impacting
outcomes.
Applying
this
AOP-aligned
approach
enables
identification
current
knowledge
gaps
orientating
for
further
research
allows
propose
biomarkers
identify
high-risk
also
facilitates
expertise
synergy
different
disciplines
address
public
issues.
Bio-Design and Manufacturing,
Год журнала:
2023,
Номер
6(6), С. 646 - 660
Опубликована: Окт. 2, 2023
Coronavirus
disease
2019
(COVID-19),
caused
by
severe
acute
respiratory
syndrome
coronavirus
2,
has
spread
globally
and
threatens
public
health.
Advanced
in
vitro
models
that
recapitulate
the
architecture
functioning
of
specific
tissues
organs
are
high
demand
for
COVID-19-related
pathology
studies
drug
screening.
Since
three-dimensional
cultures,
such
as
self-assembled
engineered
organoid
surpass
conventional
two-dimensional
cultures
animal
with
respect
to
increased
cellular
complexity,
an
environment
more
relevant
humans,
reduced
cost,
they
promising
platforms
understanding
viral
pathogenesis
developing
new
therapeutics.
This
review
highlights
recent
advances
technologies
used
COVID-19
studies.
The
challenges
future
perspectives
also
discussed.